Healthcare - Biotechnology - NASDAQ - US
$ 34.34
-7.76 %
$ 5.42 B
Market Cap
-14.07
P/E
CASH FLOW STATEMENT
-308 M
OPERATING CASH FLOW
-214 M
INVESTING CASH FLOW
644 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Ionis Pharmaceuticals, Inc.
| Net Income | -366 M |
| Depreciation & Amortization | 22.5 M |
| Capital Expenditures | -28 M |
| Stock-Based Compensation | 106 M |
| Change in Working Capital | -77.3 M |
| Others | 798 K |
| Free Cash Flow | -336 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | Dec-1997 | Dec-1996 | Dec-1995 | Dec-1994 | Dec-1993 | Dec-1992 | Dec-1991 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||||||||||||||
| Net Income | (366.3) | (269.7) | (28.6) | (486.8) | 303.3 | 215.0 | (17.3) | (86.6) | (88.3) | (39.0) | (60.6) | (65.5) | (84.8) | (61.3) | 150.7 | (12.0) | (11.0) | (45.9) | (72.4) | (142.5) | (95.0) | (72.2) | (73.8) | (53.5) | (59.2) | (43.0) | (31.1) | (26.5) | (23.7) | (18.2) | (19.1) | (19.5) | (8.7) |
| Depreciation & Amortization | 22.5 | 22.1 | 19.6 | 17.2 | 16.0 | 12.5 | 8.3 | 9.0 | 10.2 | 9.4 | 9.8 | 10.8 | 11.8 | 9.2 | 11.3 | 6.8 | 6.8 | 7.2 | 9.7 | 12.2 | 12.3 | 10.3 | 7.0 | 5.5 | 5.2 | 4.3 | 3.2 | 2.6 | 2.8 | 3.9 | 3.2 | 2.0 | 0.9 |
| Deferred Income Tax | 0 | 0 | 25.3 | 313.3 | (7.1) | (290.5) | 14.1 | 10.7 | (12.5) | (12.8) | (5.9) | (9.1) | 13.8 | 16.2 | 5.3 | (26.3) | (37.2) | (31.0) | 0.5 | (0.9) | 0 | 3.0 | (4.6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 105.8 | 100.3 | 120.7 | 230.1 | 146.6 | 131.3 | 86.0 | 72.1 | 59.3 | 31.4 | 11.4 | 8.6 | 9.8 | 12.2 | 13.4 | 15.1 | 9.9 | 5.7 | (0.5) | 0.9 | 0 | (3.0) | 4.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 7.7 | (134.6) | 7.7 | 35.7 | 55.7 | 35.2 | 39.5 | 34.1 | 31.8 | 12.1 | 22.8 | 6.9 | 1.9 | 1.5 | (185.0) | 17.5 | 14.0 | 8.2 | 9.9 | 52.8 | 11.5 | (14.4) | 35.5 | 25.7 | 15.5 | 11.4 | 0.4 | 100 K | 0.8 | (3.2) | 100 K | 0.2 | 0.6 |
| Change in Working Capital | (77.3) | 7.6 | (113.8) | (73.6) | (168.7) | 499.4 | 43.6 | (151.5) | 20.6 | 5.2 | 86.0 | 50.2 | (67.4) | (41.4) | (104.1) | 210.9 | 53.6 | 2.6 | (8.9) | (24.2) | (24.3) | (18.1) | 25.2 | (0.9) | (9.9) | (7.4) | 6.9 | 2.8 | 5.0 | 2.3 | 0.6 | (2.1) | 5.7 |
| Cash From Operations | (307.5) | (274.4) | 30.8 | 35.9 | 345.7 | 602.9 | 174.1 | (112.1) | 21.1 | 6.3 | 63.5 | 1.9 | (114.8) | (63.6) | (108.4) | 212.0 | 36.1 | (53.2) | (61.7) | (101.8) | (95.5) | (94.4) | (6.2) | (23.2) | (48.4) | (34.7) | (20.6) | (21.2) | (15.1) | (15.2) | (15.3) | (19.4) | (1.5) |
| INVESTING CASH FLOW | |||||||||||||||||||||||||||||||||
| Capital Expenditures | (28.0) | (20.1) | (17.9) | (41.0) | (36.3) | (17.7) | (37.9) | (11.5) | (11.7) | (11.1) | (5.4) | (5.2) | (11.0) | (17.6) | (16.3) | (17.1) | (5.0) | (2.6) | (0.4) | (3.5) | (7.6) | (36.8) | (9.3) | (1.6) | (4.8) | (4.4) | (3.5) | (0.9) | (1.1) | (0.9) | (5.2) | (2.1) | (2.9) |
| Other Items | (186.1) | (242.5) | 212.8 | 315.5 | (5.0) | (911.9) | (320.4) | 68.1 | (48.3) | (71.7) | (250.4) | 23.2 | 121.9 | 41.2 | (196.0) | (217.2) | (50.6) | (30.1) | 1.0 | 87.3 | (7.6) | (23.5) | (134.2) | (93.7) | (3.1) | 13.5 | (11.7) | (10.4) | (0.4) | (8.3) | (2.1) | 18.3 | (40.8) |
| Cash From Investing Activities | (214.1) | (262.6) | 194.9 | 274.5 | (41.3) | (929.6) | (358.3) | 56.6 | (60.1) | (82.8) | (255.7) | 18.0 | 110.9 | 23.7 | (212.3) | (234.2) | (55.6) | (32.6) | 0.5 | 83.7 | (15.1) | (60.4) | (143.5) | (95.4) | (7.9) | 9.1 | (15.2) | (11.3) | (1.5) | (9.2) | (7.3) | 16.2 | (43.7) |
| FINANCING CASH FLOW | |||||||||||||||||||||||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | (90.5) | (34.4) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 86.9 | (50.7) | 313.6 | 0 | 97.0 | 0 | (24.0) | (3.1) | (0.6) | 35.1 | (8.5) | 29.7 | (4.2) | 0.3 | 3.6 | 4.8 | 22.3 | (7.9) | (11.6) | 8.1 | 40.2 | 129.6 | 26.6 | 4.6 | (0.4) | 11.2 | 36.7 | 23.1 | 50.1 | 3.6 | 2.3 | (1.6) | (0.8) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 507.7 | (11.0) | (79.2) | (558.1) | (82.2) | 0 | (2.0) | 1.0 | 0.4 | 1.5 | 236.2 | 9.5 | 0 | 0 | 185.3 | 40.1 | 10.0 | 71.0 | 0 | 0 | 0 | (8.9) | 0 | 118.2 | 0 | 0 | 0 | 100 K | 0 | 100 K | 0 | 0 | 0 |
| Cash From Financing Activities | 644.1 | (55.3) | 245.9 | (596.6) | 100.0 | 475.9 | 229.1 | 11.4 | 24.7 | 59.6 | 227.7 | 39.1 | (0.7) | 4.7 | 202.0 | 107.6 | 43.6 | 149.5 | 37.6 | 12.2 | 41.9 | 129.6 | 237.0 | 122.9 | 63.9 | 15.1 | 36.7 | 23.0 | 50.1 | 3.7 | 39.9 | (1.5) | 64.5 |
| CHANGE IN CASH | |||||||||||||||||||||||||||||||||
| Net Change In Cash | 122.8 | (592.7) | 471.5 | (285.6) | 404.5 | 149.2 | 44.9 | (44.1) | (14.2) | (17.0) | 35.5 | 59.0 | (4.6) | (35.2) | (118.7) | 85.4 | 24.1 | 63.6 | (23.6) | (5.9) | (68.7) | (25.2) | 87.4 | 4.3 | 7.7 | 15.1 | 36.7 | 23.0 | 50.1 | 3.7 | 39.9 | (1.5) | 64.5 |
| FREE CASH FLOW | |||||||||||||||||||||||||||||||||
| Free Cash Flow | (335.5) | (294.5) | 12.9 | (5.2) | 309.4 | 585.2 | 136.3 | (123.6) | 9.4 | (4.8) | 58.1 | (3.3) | (125.8) | (81.1) | (124.7) | 195.0 | 31.1 | (55.8) | (62.2) | (105.3) | (103.0) | (131.2) | (15.4) | (24.8) | (53.2) | (39.1) | (24.1) | (22.1) | (16.2) | (16.1) | (20.5) | (21.5) | (4.4) |